Furthermore, siRNA-mediated knockdown of genes targeted by copy number gains including JAK3, PIM3, KPNB1 and BCL3 demonstrated that these reported STAT3-activators support HLX expression in ALCL as well (Figure 4D–4G). The gene discussed is HLX; the disease is anaplastic large cell lymphoma.